To help identify genes, which may regulate
metastasis in
lung cancer, we performed representational difference analysis between a patient-derived
non-small cell lung carcinoma (NSCLC) and immortalized normal human bronchial epithelial cells. This analysis revealed that
bone morphogenetic proteins-2/4 (BMP)
mRNA was expressed in the lung
carcinoma. BMP-2/4 are known to induce pluripotent cell differentiation, enhance cell migration and stimulate proliferation during embryonic development. Despite being powerful morphogens it is not known whether BMP-2/4 have significant biological activity in human
carcinomas. Furthermore, it has not been established whether the mature active BMP-2/4
protein is aberrantly expressed in patient-derived
tumors. The purpose of this study was to determine whether the expression of the mature BMP-2/4
protein is disregulated in human lung
carcinomas and to establish whether it has adverse biological activity. This study reveals that the mature BMP-2
protein, but not BMP-4, is highly over-expressed in human NCSLC with little to no expression in normal lung tissue or benign lung
tumors. The expression of BMP-2 localized specifically to the
cancer cells. Recombinant BMP-2 stimulated in vitro, the migration and invasiveness of the A549 and H7249 human
lung cancer cell lines. In vivo, recombinant BMP-2 enhanced the growth of
tumors formed from A549 cells injected subcutaneously into nude mice. Furthermore, inhibition of BMP-2 activity with either recombinant noggin or anti-BMP-2 antibody resulted in a significant reduction in
tumor growth. This study shows that expression of the mature BMP-2
protein is disregulated in the majority of NSCLC. BMP-2 enhancement of
tumor cell migration and invasion, as well as stimulating
tumor growth in vivo, suggests it has important biological activity in lung
carcinomas.